Research Analysts Issue Forecasts for NBIX FY2025 Earnings
Research analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Neurocrine Biosciences in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer ...
2,735 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Purchased by HB Wealth ...
HB Wealth Management LLC bought a new stake in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) during the ...
Andrew Ratz, Ph.D., Joins Neurocrine Biosciences as Senior Vice President of Drug ...
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Andrew Ratz, Ph.D., has joined the company as Senior Vice ...